Cargando…

SARS-CoV-2: An Analysis of the Vaccine Candidates Tested in Combatting and Eliminating the COVID-19 Virus

Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), better known as COVID-19, is a highly contagious virus, transferable via air droplets from close human-human contact. The pandemic has led to over 6.5 million deaths worldwide, making it the largest global health crisis since the influenz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elmancy, Laila, Alkhatib, Hala, Daou, Anis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785262/ https://www.ncbi.nlm.nih.gov/pubmed/36560496 http://dx.doi.org/10.3390/vaccines10122086

Ejemplares similares

Vaccination strategies to combat novel corona virus SARS-CoV-2
por: Pandey, Satish Chandra, et al.
Publicado: (2020)

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
por: Yi, Changhua, et al.
Publicado: (2020)

Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach
por: Mahmud, Shafi, et al.
Publicado: (2021)

SARS-CoV-2: Combating Coronavirus Emergence
por: Graham, Rachel L., et al.
Publicado: (2020)

RNAi Technology and Investigation on Possible Vaccines to Combat SARS-CoV-2 Infection
por: Talukder, Pratik, et al.
Publicado: (2021)

Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020)

Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines
por: Oliu-Barton, Miquel, et al.
Publicado: (2022)

Photodynamic therapy with curcumin for combating SARS-CoV-2
por: Law, Siukan, et al.
Publicado: (2021)

Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
por: Awadasseid, Annoor, et al.
Publicado: (2021)

A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
por: Rabaan, Ali A., et al.
Publicado: (2022)

A systematic review of SARS-CoV-2 vaccine candidates
por: Dong, Yetian, et al.
Publicado: (2020)

Identification of synthetic vaccine candidates against SARS CoV infection
por: Lien, Shu-Pei, et al.
Publicado: (2007)

Development of DNA Vaccine Candidate against SARS-CoV-2
por: Wang, Xingyun, et al.
Publicado: (2022)

Natural products as a therapy to combat against SARS-CoV-2 virus infection
por: Malviya, Shivani, et al.
Publicado: (2022)

Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques
por: Nouën, Cyril Le, et al.
Publicado: (2022)

A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets
por: Martins, Mathias, et al.
Publicado: (2023)

Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates
por: Serafim, Mateus S.M., et al.
Publicado: (2021)

Biomarkers of COVID-19 and technologies to combat SARS-CoV-2
por: Zhang, Luoping, et al.
Publicado: (2020)

Nanosponges: An overlooked promising strategy to combat SARS-CoV-2
por: Mostafavi, Ebrahim, et al.
Publicado: (2022)

Combating SARS-CoV-2: leveraging microbicidal experiences with other emerging/re-emerging viruses
por: Ijaz, M. Khalid, et al.
Publicado: (2020)

A candidate multi-epitope vaccine against SARS-CoV-2
por: Kar, Tamalika, et al.
Publicado: (2020)

A SARS-CoV-2 vaccine candidate: In-silico cloning and validation
por: Bhattacharya, Manojit, et al.
Publicado: (2020)

SARS-CoV-2–Specific Vaccine Candidates; the Contribution of Structural Vaccinology
por: Pack, Su Min, et al.
Publicado: (2022)

Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents
por: Smatti, Maria K., et al.
Publicado: (2022)

Tamarind (Tamarindus indica L.) Seed a Candidate Protein Source with Potential for Combating SARS-CoV-2 Infection in Obesity
por: Morais, Ana H. de A., et al.
Publicado: (2021)

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
por: Sun, Weina, et al.
Publicado: (2020)

New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
por: Ura, Takehiro, et al.
Publicado: (2021)

Evaluation of Four Rapid Antigen Tests for Detection of SARS-CoV-2 virus
por: Al-Alawi, Sulaiman, et al.
Publicado: (2021)

SARS-CoV-2 virus: Vaccines in development
por: Huang, Qingrui, et al.
Publicado: (2021)

Enhanced Design of PPE Based on Electrostatic Principle to Eliminate Viruses (SARS-CoV-2)
por: Kashyap, Uddip, et al.
Publicado: (2020)

Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2
por: Zhou, Hong, et al.
Publicado: (2020)

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
por: Abbott, Timothy R., et al.
Publicado: (2020)

Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages
por: Pérez-López, Briza, et al.
Publicado: (2021)

A review on the potential of photocatalysis in combatting SARS-CoV-2 in wastewater
por: Nasir, Atikah Mohd, et al.
Publicado: (2021)

Implication of nanotechnology-based approaches to combat SARS-CoV-2 infection
por: Heidari, Mana, et al.
Publicado: (2021)

SARS-CoV-2: Challenges in Reconverting Diagnostic Laboratories to Combat the Pandemic
por: Barrera Saldaña, Hugo Alberto, et al.
Publicado: (2022)

PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2
por: Mazumder, Saumyabrata, et al.
Publicado: (2021)

A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2
por: Rohaim, Mohammed A., et al.
Publicado: (2020)

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
por: Poland, Gregory A, et al.
Publicado: (2020)

Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates
por: Behr, Marcel A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j8ruvhq77fgclekk9gjt6u9aok